Walleye Trading LLC Catalyst Biosciences, Inc. Transaction History

Walleye Trading LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.91 - $4.16 $12,291 - $56,189	-13,507 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$3.78 - $5.18 $51,056 - $69,966	13,507 New	13,507 $56,000
Q2 2019 Aug 14, 2019	SELL	$7.08 - $10.6 $78,545 - $117,596	-11,094 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$7.67 - $9.96 $85,090 - $110,496	11,094 New	11,094 $90,000
Q4 2018 Feb 14, 2019	SELL	$6.59 - $11.28 $396,355 - $678,435	-60,145 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$9.35 - $12.44 $113,284 - $150,723	12,116 Added 25.23%	60,145 $648,000
Q2 2018 Aug 14, 2018	SELL	$9.11 - $28.88 $412,081 - $1.31 Million	-45,234 Reduced 48.5%	48,029 $560,000
Q1 2018 May 15, 2018	BUY	$14.18 - $35.6 $1.32 Million - $3.32 Million	93,263 New	93,263 $2.41 Million

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.